Cantor Fitzgerald Reiterates Neutral on TherapeuticsMD, Maintains $5 Price Target
BenzingaAug 17, 2023 23:48
TherapeuticsMD Analyst Ratings
BenzingaAug 17, 2023 23:47
TherapeuticsMD Analyst Ratings
Benzinga Analyst RatingsJan 11, 2023 20:46
Cantor Fitzgerald Reinstates Neutral on TherapeuticsMD, Announces $5 Price Target
Benzinga Real-time NewsJan 11, 2023 20:46
No Data
No Data